← Scroll for more →
Cardio Diagnostics Holdings, Inc. (CDIO)
In Vitro & In Vivo Diagnostic Substances
Latest Price
$1.82
Market Cap
$5.39M
TTM P/E
--
Earnings Yield
--
TTM Div Yield
--
P/B Ratio
0.94
Price at the 2026-11-06 close. Earnings yield is trailing 12-month earnings divided by price.
Business Summary
full summary →Cardio Diagnostics Holdings, Inc. (Cardio) operates in the cardiovascular diagnostic testing market, which is estimated to grow from $8.47 billion in 2022 to $12.41 billion by 2027, representing a Compound Annual Growth Rate (CAGR) of 7.94%.
Price
full chart →- 1-Year Change
- -55.62%
- 52-Week High
- $7.91
- 52-Week Low
- $0.97
Daily close, 2025-11-06 to 2026-11-06
Financials
financial statements →| Quarter ending | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Last 4 quarters |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $950 | $0 | $1,725 | $10,030 | $5,310 | $15,928 | $7,870 | $6,580 | $4,512 | $940 | $7,475 | $2,855 | $3,555 | $2,680 | $5,360 | $3,590 | $15,185 |
| Operating margin | -384998.8% | -- | -148008.2% | -14398.7% | -29039.5% | -26105.3% | -16295.5% | -21412.9% | -33608.2% | -173463.8% | -22457.5% | -59950.9% | -41159.6% | -66598.4% | -27950.5% | -48193.8% | -42649.8% |
| Net income | -$4.15M | -$1.03M | -$4.02M | -$1.93M | -$1.39M | -$4.16M | -$1.29M | -$1.41M | -$1.52M | -$1.64M | -$1.68M | -$1.71M | -$1.47M | -$1.79M | -$1.50M | -$1.73M | -$6.49M |
| Net margin | -436625.3% | -- | -233211.9% | -19266.0% | -26156.8% | -26140.0% | -16365.9% | -21467.6% | -33672.6% | -173943.0% | -22517.7% | -60053.8% | -41219.9% | -66722.3% | -28012.5% | -48254.3% | -42721.9% |
| Operating cash flow | -$4.50M | -$1.65M | -$1.29M | -$1.04M | -$1.69M | -$1.23M | -$1.21M | -$1.16M | -$1.39M | -$1.40M | -$1.57M | -$1.39M | -$1.36M | -$1.56M | -$1.34M | -$1.52M | -$5.78M |
| Free cash flow | -- | -- | -- | -$1.06M | -$2.22M | -$1.25M | -$1.38M | -$1.18M | -$1.40M | -$1.41M | -$1.59M | -$1.56M | -$1.36M | -$1.56M | -$1.34M | -$1.52M | -$5.78M |
Chart: revenue per quarter, Dec 2022 to Sep 2026. Hover over or tap a row to chart it.
Quarters ending Dec 2024 to Sep 2026, oldest first.
Revenue ($K)
Last 4 quarters $15,185
$8K$0
4.510.947.472.853.562.685.363.59
Operating margin (%)
Last 4 quarters -42649.8%
0%-200000%
-34K-173K-22K-60K-41K-67K-28K-48K
Net income ($M)
Last 4 quarters -$6.49M
$0-$2M
-1.5-1.6-1.7-1.7-1.5-1.8-1.5-1.7
Net margin (%)
Last 4 quarters -42721.9%
0%-200000%
-34K-174K-23K-60K-41K-67K-28K-48K
Operating cash flow ($M)
Last 4 quarters -$5.78M
$0-$2M
-1.4-1.4-1.6-1.4-1.4-1.6-1.3-1.5
Free cash flow ($M)
Last 4 quarters -$5.78M
$0-$2M
-1.4-1.4-1.6-1.6-1.4-1.6-1.3-1.5
Capital Structure
balance sheet →- Shares Outstanding
- 2.96M
- Total Debt
- --
- Long-term Debt
- --
- Long-term Debt / Capital
- --
- Cash
- $0
- Current Assets
- $4.35M
- Current Liabilities
- $249,619
Current position as of 2026-09-30.
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 49.2K | -- | 1.66% | +33.9K | 2026-06-30 |
| BlackRock, Inc. | 34.7K | -- | 1.17% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 26.2K | -- | 0.89% | -5.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 20.2K | -- | 0.68% | -- | 2026-06-30 |
| Citadel Advisors LLC | 19.1K | -- | 0.64% | +8.2K | 2026-06-30 |
| XTX Topco Ltd | 16.1K | -- | 0.54% | -- | 2026-06-30 |
| Jane Street Group, LLC | 11.9K | -- | 0.40% | -69.3K | 2026-06-30 |
| State Street Corp | 10.1K | -- | 0.34% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 2.8K | -- | 0.10% | -1.1K | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 1.8K | -- | 0.06% | -383 | 2026-06-30 |